Idiopathic intracranial hypertension: Mechanisms of visual loss and disease management

Seminars in Neurology

Volumn 20, Issue 1, 2000, Pages 89-95

  Wall, Michael ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Intracranial hypertension; Pseudotumor cerebri; Visual loss

Indexed keywords

ACETAZOLAMIDE; FUROSEMIDE;

ARTICLE; BRAIN ISCHEMIA; BRAIN PSEUDOTUMOR; DRUG RESPONSE; HUMAN; INTRACRANIAL HYPERTENSION; MORBIDITY; OPTIC NERVE DISEASE; PAPILLEDEMA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; VISUAL IMPAIRMENT;

AGE FACTORS; FEMALE; HUMANS; INTRACRANIAL HYPERTENSION; PAPILLEDEMA; SEX FACTORS; VISION, LOW;

EID: 0033937780     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Orcutt JC, Page NG, Sanders MD. Factors affecting visual loss in benign intracranial hypertension. Ophthalmology 1984;91: 1303-1312
2. Grehn F, Knorr-Held S, Kommerell G. Glaucomatous like visual field defects in chronic papilledema. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1981;217:99-109
3. Wall M, White WN. Asymmetric papilledema in idiopathic intracranial hypertension: Prospective interocular comparison of sensory visual function. Invest Ophthalmol Vis Sci 1998;39: 134-142
4. Hayreh SS. Optic disc edema in raised intracranial pressure. V. Pathogenesis. Arch Ophthalmol 1977;95:1553-1565
5. Wall M, George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain 1991;114:155-180
6. Kirkham TH, Sanders MD, Sapp GA. Unilateral papilloedema in benign intracranial hypertension. Can J Ophthalmol 1973;8: 533-538
7. Muci-Mendoza R, Arruga J, Hoyt WF. Distension bilateral del espacio subaracnoideo perioptico en el pseudotumor cerebral con papiledema unilateral. Rev Neurol (Barcelona) 1981;39:11-15
8. Strominger MB, Weiss GB, Mehler MF. Asymptomatic unilateral papilledema in pseudotumor cerebri. J Clin Neurol Ophthalmol 1992;12:238-241
9. Rosenberg M, Huna R, Warren FA, Kupersmith MJ. Unilateral papilledema due to increased intracranial pressure. Invest Ophthalmol Vis Sci 1996;37:5690
10. To KW, Warren FA. Unilateral papilledema in pseudotumor cerebri. Arch Ophthalmol 1990;108:644-645
11. Hayreh SS. The sheath of the optic nerve. Ophthalmologica (Basel) 1984;189:54-63
12. Hayreh SS. Pathogenesis of optic disc oedema in raised intracranial pressure. Trans Ophthalmol Soc UK 1976;96:404-407
13. Hayreh SS. Optic disc edema in raised intracranial pressure. V. Pathogenesis. Arch Ophthalmol 1977;95:1553-1565
14. Hayreh SS, March W, Anderson DR. Pathogenesis of block of rapid orthograde axonal transport by elevated intraocular pressure. Exp Eye Res 1979;28:515-523
15. Tso MO, Hayreh SS. Optic disc edema in raised intracranial pressure. IV. Axoplasmic transport in experimental papilledema. Arch Ophthalmol 1977;95:1458-1462
16. Wall M, Montgomery EB. Using motion perimetry to detect visual field detects in patients with idiopathic intracranial hypertension: A comparison with conventional automated perimetry. Neurology 1995;45:1169-1175
17. Tytla ME, Buncic JR. Optic nerve compression impairs low spatial frequency vision in man. Clin Vis Sci 1988;2:179-186
18. Wall M, White WN. Asymmetric papilledema in idiopathic intracranial hypertension: prospective interocular comparison of sensory visual function. Invest Ophthalmol Vis Sci 1998; 39:134-142
19. Newborg B. Pseudotumor cerebri treated by rice reduction diet. Arch Intern Med 1974;133:802-807
20. Johnson LN, Krohel GB, Madsen RW, March GA, Jr. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology 1998;105:2313-2317
21. Kupersmith MJ, Gamell L, Turbin R, Peck V, Spiegel P, Wall M. Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology 1998;50:1094-1098
22. Greer M. Benign intracranial hypertension. VI. Obesity. Neurology 1965;15:382-388
23. Amoral JF, Tsiaris W, Morgan T, Thompson WR. Reversal of benign intracranial hypertension by surgically induced weight loss. Arch Surg 1987;122:946-949
24. Sugerman HJ, Felton WL3, Salvant JB, Jr., Sismanis A, Kellum JM. Effects of surgically induced weight loss on idiopathic intracranial hypertension in morbid obesity. Neurology 1995;45: 1655-1659
25. Friedman DI, Streeten DH. Idiopathic intracranial hypertension and orthostatic edema may share a common pathogenesis. Neurology 1998;50:1099-1 04
26. Kupersmith MJ, Gamell L, Turbin R, Peck V, Spiegel P, Wall M. Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology 1998;50:1094-1098
27. Weisberg LA. Benign intracranial hypertension. Medicine 1975; 54:197-207
28. Paterson R, DePasquale N, Mann S. Pseudotumor cerebri. Medicine 1961;40:85-99
29. Weisberg LA, Chutorian AM. Pseudotumor cerebri of childhood. Am J Dis Child 1977;131:1243-1248
30. Gücer G, Vierenstein L. Long-term intracranial pressure recording in management of pseudotumor cerebri. J Neurosurg 1978; 49:256-263
31. Tomsak RL, Niffenegger AS, Remler BF. Treatment of pseudotumor cerebri with Diamox (acetazolamide). J Clin Neuroophthalmol 1988;8:93-98
32. Corbett JJ. The 1982 Silversides lecture. Problems in the diagnosis and treatment of pseudotumor cerebri. Can J Neurol Sci 1983;10:221-229
33. Eggenberger ER, Miller NR, Vitale S. Lumboperitoneal shunt for the treatment of pseudotumor cerebri. Neurology 1996;46: 1524-1530
34. Burgett RA, Purvin VA, Kawasaki A. Lumboperitoneal shunting for pseudotumorcerebri. Neurology 1997;49:734-739
35. Rosenberg ML, Corbett JJ, Smith C, et al. Cerebrospinal fluid diversion procedures in pseudotumorcerebri. Neurology 1993;43: 1071-1072
36. Sergott RC, Savino PJ, Bosley TM. Modified optic nerve sheath decompression provides long-term visual improvement for pseudotumorcerebri. Arch Ophthalmol 1988;106:1384-1390
37. Corbett JJ, Nerad JA, Tse DT, Anderson RL. Results of optic nerve sheath fenestration for pseudotumor cerebri. The lateral orbitotomy approach. Arch Ophthalmol 1988;106:1391-1397
38. Sergott RC, Savino PJ, Bosley TM. Optic nerve sheath decompressions clinical review and proposed pathophysiologic mechanism. Aust NZ J Ophthalmol 1990;18:365-373
39. Spoor TC, Ramocki JM, Madion MP, Wilkinson MJ. Treatment of pseudotumor cerebri by primary and secondary optic nerve sheath decompression. Am J Ophthalmol 1991;112:177-185
40. Brourman ND, Spoor TC, Ramocki JM. Optic nerve sheath decompression for pseudotumor cerebri. Arch Ophthalmol 1988; 106:1378-1383
41. Corbett JJ, Nerad JA, Tse D, Anderson RL. Optic nerve sheath fenestration for pseudotumor cerebri: The lateral orbitotomy approach. Arch Ophthalmol 1988;106:1391-1397
42. Keltner J. Optic nerve sheath decompression:how does it work? Has its time come? Arch Ophthalmol 1988;106:1378-1383
43. Acheson JF, Green WT, Sanders MD. Optic nerve sheath decompression for the treatment of visual failure in chronic raised intracranial pressure. J Neurol Neurosurg Psychiatry 1994;57: 1426-1429
44. Hamed LM, Tse DT, Glaser JS, Byrne SF, Schatz NJ. Neuroimaging of the optic nerve after fenestration for management of pseudotumor cerebri. Arch Ophthalmol 1992;110:636-639
45. Smith CH, Orcutt JC. Surgical treatment of pseudotumor cerebri. Int Ophthalmol Clin 1986;26:265-275
46. Spoor TC, McHenry JG. Long-term effectiveness of optic nerve sheath decompression for pseudotumor cerebri. Arch Ophthalmol 1993;111:632-635
47. Wall M, Johnson CA, Kutzko KS, Nguyen R, Brito CF, Keltner JL. Long- and short-term variability of automated perimetry results in patients with optic neuritis and healthy subjects. Arch Ophthalmol 1998:53-61
48. Digre KB, Corbett JJ. Pseudotumor cerebri in men. Arch Neurol 1988;45:866-872